A case of X-linked hypophosphatemic rickets: Complications and the therapeutic use of cinacalcet

European Journal of Endocrinology

Volumn 159, Issue SUPPL. 1, 2008, Pages

  Ræder, Helge ^a,b   Shaw, Nick ^c   Netelenbos, Coen ^d   Bjerknes, Robert ^a,b  

^a UNIVERSITY OF BERGEN   (Norway)

^b HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^c BIRMINGHAM CHILDREN S HOSPITAL   (United Kingdom)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; ALFACALCIDOL; CINACALCET; LABETALOL; NIFEDIPINE; OXYGENASE; PARATHYROID HORMONE; PHOSPHATE; PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PHOSPHORUS; SODIUM PHOSPHATE COTRANSPORTER; 1-HYDROXYCHOLECALCIFEROL; BONE DENSITY CONSERVATION AGENT; HYDROXYCOLECALCIFEROL; NAPHTHALENE DERIVATIVE; PHEX PROTEIN, HUMAN; UNCLASSIFIED DRUG;

BONE MALFORMATION; CALCIUM METABOLISM; CASE REPORT; CONFERENCE PAPER; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; EPSTEIN BARR VIRUS; FEMALE; GENE MUTATION; GROWTH RETARDATION; HUMAN; HUMAN TISSUE; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERTENSION; KIDNEY BIOPSY; KIDNEY CALCIFICATION; KIDNEY TUBULE CELL; MISSENSE MUTATION; NEWBORN; PARATHYROID HORMONE BLOOD LEVEL; PATHOPHYSIOLOGY; PHOSPHATE BLOOD LEVEL; PHOSPHATE METABOLISM; PHOSPHATURIA; SECONDARY HYPERPARATHYROIDISM; VIRUS INFECTION; X LINKED HYPOPHOSPHATEMIC RICKETS; ARTICLE; CHEMICALLY INDUCED DISORDER; GENETICS; INFANT; KIDNEY FAILURE; ORAL DRUG ADMINISTRATION;

ADMINISTRATION, ORAL; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; HYDROXYCHOLECALCIFEROLS; HYPERCALCEMIA; HYPERPARATHYROIDISM; HYPERTENSION; HYPOPHOSPHATEMIC RICKETS, X-LINKED DOMINANT; INFANT; KIDNEY FAILURE; MUTATION, MISSENSE; NAPHTHALENES; NEPHROCALCINOSIS; PHEX PHOSPHATE REGULATING NEUTRAL ENDOPEPTIDASE; PHOSPHATES;

EID: 58749096034     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-08-0383     Document Type: Conference Paper

References (13)

1. Quarles LD. Evidence for a bone-kidney axis regulating phosphate homeostasis. Journal of Clinical Investigation 2003 112 642-646.
2. Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J & Juppner H. Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. New England Journal of Medicine 2003 348 1656-1663.
3. Verge CF, Lam A, Simpson JM, Cowell CT, Howard NJ & Silink M. Effects of therapy in X-linked hypophosphatemic rickets. New England Journal of Medicine 1991 325 1843-1848.
4. Schmitt CP & Mehls O. The enigma of hyperparathyroidism in hypophosphatemic rickets. Pediatric Nephrology 2004 19 473-477.
5. Alon US, Monzavi R, Lilien M, Rasoulpour M, Geffner ME & Yadin O. Hypertension in hypophosphatemic rickets - role of secondary hyperparathyroidism. Pediatric Nephrology 2003 18 155-158.
6. Nehgme R, Fahey JT, Smith C & Carpenter TO. Cardiovascular abnormalities in patients with X-linked hypophosphatemia. Journal of Clinical Endocrinology and Metabolism 1997 82 2450-2454.
7. Block GA, Martin KJ, de Francisco AL, Turner SA, Avram MM, Suranyi MG, Hercz G, Cunningham J, Abu-Alfa AK, Messa P, Coyne DW, Locatelli F, Cohen RM, Evenepoel P, Moe SM, Fournier A, Braun J, McCary LC, Zani VJ, Olson KA, Drueke TB & GoodmanWG. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis. New England Journal of Medicine 2004 350 1516-1525.
8. Alon US, Levy-Olomucki R, Moore WV, Stubbs J, Liu S & Quarles LD. Calcimimetics as an adjuvant treatment for familial hypophosphatemic rickets. Clinical Journal of the American Society of Nephrology 2008 3 658-664.
9. Patriquin H & Robitaille P. Renal calcium deposition in children: sonographic demonstration of the Anderson-Carr progression. American Journal of Roentgenology 1986 146 1253-1256.
10. Eddy MC, McAlister WH & Whyte MP. X-linked hypophosphatemia: normal renal function despite medullary nephrocalcinosis 25 years after transient vitamin D2-induced renal azotemia. Bone 1997 21 515-520.
11. Alon U, Donaldson DL, Hellerstein S, Warady BA & Harris DJ. Metabolic and histologic investigation of the nature of nephrocalcinosis in children with hypophosphatemic rickets and in the Hyp mouse. Journal of Pediatrics 1992 120 899-905.
12. Dong BJ. Cinacalcet: an oral calcimimetic agent for the management of hyperparathyroidism. Clinical Therapeutics 2005 27 1725-1751.
13. de Francisco AL. New strategies for the treatment of hyperparathyroidism incorporating calcimimetics. Expert Opinion on Pharmacotherapy 2008 9 795-811.